GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Godavari Drugs Ltd

Godavari Drugs Board Approves Equity Allotment on Warrant Conversion

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 14 Aug 2026, 01:05 PM IST  ·  BSE ID: 8eff5c22-48e5-4078-a6a3-736b943a41f0
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors agreed to convert warrants into shares, raising more capital by issuing new shares to promoters.
🤖 AI Summary
  • Board approves allotment of 7,86,690 equity shares on warrant conversion.
  • Issue price fixed at Rs. 89 per share, with Rs. 10 premium.
  • Converts warrants for Rs. 5,25,11,557.5 to equity shares.
  • Paid-up equity capital increases to Rs. 10,91,41,250.
  • Allotment made to Promoters Category on a preferential basis.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Number of Equity Shares Allotted
7,86,690
Issue Price per Share
Rs. 89/-
Premium per Share
Rs. 10/-
Amount Received on Conversion
Rs. 5,25,11,557.5/-
Old Paid-up Equity Capital
Rs. 10,12,74,350/-
New Paid-up Equity Capital
Rs. 10,91,41,250/-
Old Number of Equity Shares
1,01,27,435
New Number of Equity Shares
1,09,14,125
Face Value per Share
Rs. 10/-
Outstanding Warrants
15,73,375
🏢 How This Affects the Company
💰
Financial Impact
The paid-up equity capital of the company has increased from Rs. 10,12,74,350 to Rs. 10,91,41,250 following the conversion of warrants into equity shares.
👥 What This Means For Shareholders
✅
Action Required
No action is required from existing shareholders regarding this allotment.
👤
Who Is Affected
Shareholders are affected by the increase in total equity shares outstanding.
🔍
Management Signal
Management is executing on its approved preferential allotment strategy to raise capital.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Further conversions of remaining outstanding warrants.
Disclosure of next quarter's financial results.
Updates on any further capital raising initiatives.
LOW RISK Standard execution of prior approved warrant conversion process.
💡 Investor Takeaway
Godavari Drugs' Board approved allotting 7,86,690 equity shares on warrant conversion at Rs. 89 each, increasing paid-up capital to Rs. 10,91,41,250.
⚖️ Strengths & Concerns

✅ Positives

  • Completion of warrant conversion increases paid-up equity capital to Rs. 10,91,41,250.
  • Promoter category conversion confirms continued commitment and capital infusion.

⚠️ Concerns

  • 15,73,375 warrants remain outstanding for future conversion.
  • Significant portion of warrant issuance price (75%) was paid upon conversion.
❓ Frequently Asked Questions
How many equity shares did Godavari Drugs allot on warrant conversion?
Godavari Drugs allotted 7,86,690 equity shares upon conversion of warrants.
What is the issue price for the new equity shares?
The issue price for the new equity shares is Rs. 89/- each, including a premium of Rs. 10/-.
What is the total amount received on conversion of these warrants?
The company received Rs. 5,25,11,557.5/- on conversion of these warrants.
What is the new paid-up equity capital of Godavari Drugs after allotment?
The paid-up equity capital of Godavari Drugs has increased to Rs. 10,91,41,250/-.
Who are the allottees of these newly converted equity shares?
The equity shares were allotted to the 'Promoters Category' on a preferential basis.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.